Comment
Crohn's disease of the colon is beset by difficulties in terminology, and its true incidence is hard to determine. Of all cases of Crohn's disease, probably 5 % initially involve the colon, with 50 % ultimately having some colonic involvement (Brooke 1959) . Massive haemorrhage is a rare complication, and only 6 cases are documented (Goldberg & Frable 1963) . The differential diagnosis between Crohn's disease of the colon and ulcerative colitis is sometimes difficult but has been clearly defined by Lockhart-Mummery & Morson (1960), Meadows et al. (1963 ), Lindner et al. (1963 , Saltzstein & Rosenberg (1963) and Sutcliffe (1963) . Table 1 is a summary of the main differentiating features.
Initially, the diagnosis was based on the radiology and history, but later the type and distribution of the ulceration, as seen in the specimen, supported a diagnosis of Crohn's disease involving both ileum and colon.
The influence of prednisone is problematical, but it may have prevented the expected fibrosis and possibly was a factor in the massive heemorrhage. The renal colic and heematuria are unexplained, for at operation renal biopsy was normal. Congenital thyrotoxicosis is a rare disorder affecting infants of women with a past and/or present history of thyrotoxicosis. Some 18 cases have been reported; the first reported case (White 1912 ) and a further case (Margetts 1950 ) were shown at the Royal Society of Medicine. Sclare (1960) reviewed 12 cases reported before 1957, 3 of whom died, and Javett et al. (1959) Saxena et al. (1964) found only one case of neonatal thyrotoxicosis among 70 juvenile thyrotoxic patients.
Congenital Thyrotoxicosis with

Case Report
The mother, now aged 30, developed thyrotoxic goitre with exophthalmos at the age of 18; partial thyroidectomy was carried out two years later; exophthalmos worsened and pretibial myxcedema developed (see Blanshard 1956 ). Her first pregnancy, at 27, ended at 36 weeks. The 4 lb 6 oz premature male infant had hepatosplenomegaly, purpura, respiratory distress and jaundice, and died in twenty-four hours. Platelets were not counted.
During her second pregnancy, which ended at 36 weeks, antithyroid and thyroid drugs were withheld and meprobamate was given. The 4i lb male infant, who received hydrocortisone, digoxin and Lugol's iodine, died at 11 days with thyrotoxicosis, jaundice, respiratory distress, hepatosplenomegaly, purpura and thrombocytopenia. Platelets were absent at birth, but 22,000/ c.mm by the tenth day. Platelet antibody negative in mother's blood, by Coombs consumption technique. Thyroid gland weighed 4 g; the histology was compatible with thyrotoxicosis. The LATS concentration in the mother's serum was reported to be high (Dr D S Munro). During her third pregnancy, she was given tri-iodothyronine until the seventh month and then carbimazole 30 mg daily (Dr D Ferriman). She was almost euthyroid at delivery and remained well without drugs afterwards. The infant, a female weighing 6 lb 3 oz and 51 cm (20 in.) in length, was delivered normally at 381 weeks, at the North Middlesex Hospital. At birth: heart rate 140, respiration 50 per min; very hyperkinetic; eyelids puffy; exophthalmos; gynaecomastia; enlarged thyroid gland; liver palpable 2-5 cm below costal margin; Hb 23-2 g/100 ml; platelets 70,000/c.mm. Within three hours the hyperkinesis settled. She was overactive on being handled during the second day. By the third day the spleen was palpable, hepatosplenomegaly had increased and platelets were 1 50,000/c.mm. Respiration irregular. Sucking reflex absent. Eyes (Mr C G Keith): Bilateral aniridia, anterior dislocation of lenses, bilateral corneal opacities and oscillatory nystagmus. Optic fundi normal. During the 5th, 6th and 7th days the infant developed tachycardia up to 190/min. (see Fig 1) , tachypnoea, grunting, irregular respirations and engorged neck veins. Hepatosplenomegaly increased. Eight to 9 loose stools per day. No bruit over thyroid gland. No increased sweating. Severe hypotonia.
Treatment (see Fig 1) : Nursed in oxygen. From 7th day: carbimazole 1 mg twelve-hourly, phenobarbitone and digoxin. Lugol's iodine, 1 minim eight-hourly, added after twenty-four hours. Phenobarbitone discontinued on thirteenth day and digoxin on fourteenth day. Antithyroid drugs slowly reduced because of lethargy, hypotonia and drooling (? hypothyroid state), and discontinued at 6 weeks. Discharged at 8 weeks:
weight 9 lb 12 oz. Hypotonic, and head lag. Liver enlarged. Spleen just palpable.
Progress: At 10th week: liver normal and spleen not palpable. At 7 months: apart from nystagmus and impaired vision, physical development normal. Corneal opacities less dense.
Comment
This typical case of congenital thyrotoxicosis was treated ante-and post-natally by antithyroid drugs. Jaundice and hepatosplenomegaly have been described with congenital thyrotoxicosis (Skelton & Gans 1955 , Clinical Pathological Conference 1959 . Platelet counts at birth have not been recorded in reported cases of congenital thyrotoxicosis. However, Frisk & Josefsson (1947) observed a 'normal blood picture' including sternal marrow. We do not know whether purpura or thrombocytopenia is due to thyrotoxicosis or whether it is related to drugs given to the mother during pregnancy. The association of aniridia and dislocated lenses with thyroid disorders has not been reported and is believed to be a coincidence in this case.
Adams et al. (1964) explained features of congenital thyrotoxicosis by the hypothesis that it -is due to stimulation of the infant's-thyroid by LATS which has crossed from the maternal to the foetal circulation. LATS may be a y-globulin comparable to maternal antibodies and provides an explanation for the self-limiting course of a few weeks of this disorder. One wonders what the role of the pituitary may be if LATS is possibly an antibody produced at a site different from the pituitary.
Estimation of the LATS level in pregnant women likely to produce thyrotoxic infants is desirable, particularly in those who have already had an affected child. Major & Munro (1960) found a very high blood LATS level in such a case. Antithyroid drugs given during the last six to seven months of pregnancy are helpful in saving the baby. Adams et al. (1964) recommend thyroxine to be given simultaneously with antithyroid drugs. Platelet counts in the neonatal period would be of interest.
